- Home
- SUZ vs MDAIW Comparison
SUZ vs MDAIW Comparison
Compare SUZ & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUZ
- MDAIW
- Stock Information
- Founded
- SUZ 1924
- MDAIW N/A
- Country
- SUZ Brazil
- MDAIW United States
- Employees
- SUZ N/A
- MDAIW 78
- Industry
- SUZ Paper
- MDAIW Medical/Dental Instruments
- Sector
- SUZ Basic Materials
- MDAIW Health Care
- Exchange
- SUZ Nasdaq
- MDAIW Nasdaq
- Market Cap
- SUZ 11.6B
- MDAIW N/A
- IPO Year
- SUZ N/A
- MDAIW N/A
- Fundamental
- Price
- SUZ $8.68
- MDAIW $0.37
- Analyst Decision
- SUZ
- MDAIW
- Analyst Count
- SUZ 0
- MDAIW 0
- Target Price
- SUZ N/A
- MDAIW N/A
- AVG Volume (30 Days)
- SUZ 1.8M
- MDAIW 35.6K
- Earning Date
- SUZ 05-08-2025
- MDAIW 02-27-2025
- Dividend Yield
- SUZ 3.11%
- MDAIW N/A
- EPS Growth
- SUZ N/A
- MDAIW N/A
- EPS
- SUZ N/A
- MDAIW N/A
- Revenue
- SUZ $8,633,051,515.00
- MDAIW $27,264,000.00
- Revenue This Year
- SUZ $17.17
- MDAIW N/A
- Revenue Next Year
- SUZ $9.27
- MDAIW N/A
- P/E Ratio
- SUZ N/A
- MDAIW N/A
- Revenue Growth
- SUZ 30.47
- MDAIW 44.52
- 52 Week Low
- SUZ $8.41
- MDAIW $0.08
- 52 Week High
- SUZ $10.98
- MDAIW $0.90
- Technical
- Relative Strength Index (RSI)
- SUZ 33.54
- MDAIW N/A
- Support Level
- SUZ $9.32
- MDAIW N/A
- Resistance Level
- SUZ $9.55
- MDAIW N/A
- Average True Range (ATR)
- SUZ 0.17
- MDAIW 0.00
- MACD
- SUZ -0.06
- MDAIW 0.00
- Stochastic Oscillator
- SUZ 1.98
- MDAIW 0.00
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About MDAIW Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.